Troxipide
Troxipide is a novel systemic non-antisecretory gastric cytoprotective agent with anti-ulcer, anti-inflammatory and mucus secreting properties irrespective of pH of stomach or duodenum. (In Vitro) :Troxipide exerts inhibitory, therapeutic and preventive effects to specifically those in the stomach by enhancing gastric mucosal blood flow and gastric mucosal defense factors and promoting tissue repair, blood circulation, metabolism and GU repair. (In Vivo) :Troxipide (40 mg/kg; iv) significantly alleviates gastric ulcer (GU) .Troxipide (40 mg/kg; iv) has a T1/2 of 210 min and 428.73 min for NCG and GUG rat, respectively.
Product Specifications
CAS Number
30751-05-4
Product Name Alternative
BRN0493078 | Troxipide | Troxipida | Troxipidum
Field of Research
Pharmacology & Drug Discovery
Purity
>98% (HPLC)
Solubility
Ethanol: 3 mg/mL (10.19 mM) ; DMSO: 18 mg/mL (61.15 mM)
Smiles
O=C (NC1CNCCC1) C2=CC (OC) =C (OC) C (OC) =C2
Molecular Formula
C15H22N2O4
Molecular Weight
294.35
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
3,4,5-trimethoxy-N- (piperidin-3-yl) benzamide
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
HRP-Linked Polyclonal Antibody to Fascin (FSCN)
HRP-Linked Polyclonal Antibody to Fascin (FSCN)
HRP-Linked Polyclonal Antibody to Fascin (FSCN)